凯德诊断

最新新闻

• Craig-Hallum Upgrades CareDx(CDNA.US) to Buy Rating, Raises Target Price to $64
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  Craig-Hallum Upgrades CareDx(CDNA.US) to Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/1/14
• 评级变动
  Craig-Hallum Maintains CareDx(CDNA.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/25
• BTIG Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $74
  \u5e02\u573a\u8d44\u8baf · 2026/9/24
• 评级变动
  H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/4/30
• 评级变动
  William Blair Maintains CareDx(CDNA.US) With Hold Rating, Announces Target Price $21.91
  \u5e02\u573a\u8d44\u8baf · 2026/4/29
• William Blair Maintains CareDx(CDNA.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  Craig-Hallum Downgrades CareDx(CDNA.US) to Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/1/23
• 评级变动
  H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating, Announces Target Price $46
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  A Quick Look at Today's Ratings for CareDx(CDNA.US), With a Forecast Between $35 to $45
  \u5e02\u573a\u8d44\u8baf · 2026/7/17
• CCORF Initiates CareDx(CDNA.US) With Buy Rating, Announces Target Price $65
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 评级变动
  Craig-Hallum Maintains CareDx(CDNA.US) With Buy Rating, Announces Target Price $26
  \u5e02\u573a\u8d44\u8baf · 2025/11/25
• 评级变动
  H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating, Announces Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/3/9
• 评级变动
  BTIG Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $28
  \u5e02\u573a\u8d44\u8baf · 2026/4/29
• BTIG Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $60
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• 评级变动
  Wells Fargo Maintains CareDx(CDNA.US) With Hold Rating, Raises Target Price to $21
  \u5e02\u573a\u8d44\u8baf · 2026/2/25
• 评级变动
  Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Atai Beckley N.V. (ATAI)
  TipRanks · 2026/2/25
• 评级变动
  BTIG Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $26
  \u5e02\u573a\u8d44\u8baf · 2026/2/26
• 评级变动
  Craig-Hallum Downgrades CareDx(CDNA.US) to Hold Rating, Maintains Target Price $26
  \u5e02\u573a\u8d44\u8baf · 2026/1/6
• 评级变动
  A Quick Look at Today's Ratings for CareDx(CDNA.US), With a Forecast Between $21.91 to $28
  \u5e02\u573a\u8d44\u8baf · 2026/4/30

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。